COMPASS Pathways plc (id:8071 CMPS)
4.57 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/25/2024 10:05:23 PM)
Exchange closed, opens in 11 hours 24 minutes
1.56 USD (1.56%)
-1.08 USD (-1.08%)
-26.88 USD (-26.88%)
-39.95 USD (-39.95%)
-30.34 USD (-30.34%)
-80.47 USD (-80.47%)
About COMPASS Pathways plc
Market Capitalization 344.84M
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
| Headquarters (address) |
33 Broadwick Street London W1F 0DQ United Kingdom |
| Phone | 44 71 6676 6461 |
| Website | https://compasspathways.com |
| Employees | 186 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Ticker | CMPS |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 4.05 - 12.75 |
| Market Capitalization | 344.84M |
| P/E trailing | -1.90 |
| P/E forward | -2.45 |
| Price/Book | 1.79 |
| Beta | 2.30 |
| EPS | -2.18 |
| EPS United Kingdom (ID:3, base:637) | 0.423 |